Application Sponsors
ANDA 065046 | HIKMA FARMACEUTICA | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | EQ 7.5GM BASE/VIAL | 0 | CEFUROXIME SODIUM | CEFUROXIME SODIUM |
FDA Submissions
| ORIG | 1 | AP | 2004-01-09 | |
LABELING; Labeling | SUPPL | 3 | AP | 2008-08-25 | |
LABELING; Labeling | SUPPL | 9 | AP | 2016-05-06 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2019-11-16 | STANDARD |
LABELING; Labeling | SUPPL | 12 | AP | 2021-07-07 | STANDARD |
LABELING; Labeling | SUPPL | 13 | AP | 2021-07-07 | STANDARD |
Submissions Property Types
SUPPL | 9 | Null | 15 |
SUPPL | 11 | Null | 31 |
SUPPL | 12 | Null | 15 |
SUPPL | 13 | Null | 15 |
TE Codes
CDER Filings
HIKMA FARMACEUTICA
cder:Array
(
[0] => Array
(
[ApplNo] => 65046
[companyName] => HIKMA FARMACEUTICA
[docInserts] => ["",""]
[products] => [{"drugName":"CEFUROXIME SODIUM","activeIngredients":"CEFUROXIME SODIUM","strength":"EQ 7.5GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"CEFUROXIME SODIUM","submission":"CEFUROXIME SODIUM","actionType":"EQ 7.5GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)